Long-term treatment with high-dose of sildenafil in a thalassemic patient with pulmonary hypertension

Submitted: December 1, 2015
Accepted: December 1, 2015
Published: December 1, 2015
Abstract Views: 913
PDF: 630
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We report a case of a 37-years-old man, affected by thalassemia major, hypogonadotropic hypogonadism, chronic HCV-hepatitis, diabetes mellitus, severe osteoporosis, prior septic pulmonary embolism and pulmonary artery hypertension was performed a long-term treatment with highdose of sildenafil (120 mg/die) with reduction of pulmonary arterial systolic pressure and of the dyspnea.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Correale, Michele, Fiorella De Rosa, Riccardo Ieva, Matteo Di Biase, and Natale Daniele Brunetti. 2015. “Long-Term Treatment With High-Dose of Sildenafil in a Thalassemic Patient With Pulmonary Hypertension”. Monaldi Archives for Chest Disease 78 (2). https://doi.org/10.4081/monaldi.2012.131.